Abbott announced that the Food and Drug Administration (FDA) has approved the Tecnis Symfony Intraocular Lenses for the treatment of cataracts. Abbott announced that the Food and Drug Administration ...

Please provide your email address to receive an email when new articles are posted on . With advancing technology, cataract surgery is now less invasive, resulting in better recovery and outcomes. Not ...

Abbott has earned FDA approval for its Tecnis Symfony Intraocular Lenses for the treatment of cataracts. The approval includes the Tecnis Symfony Toric IOL, a version of the lenses that are made for ...

ABBOTT PARK, Ill., June 24, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the TECNIS ® Symfony Extended Range of Vision ...

A long-awaited revolution in intraocular lenses (IOLs) made its Utah and Intermountain West debut in the hands of cataract surgeon, Alan S. Crandall, MD, at the University of Utah's John A. Moran Eye ...

The U.S. Food and Drug Administration (FDA) has approved Abbott’s Tecnis Symfony Intraocular Lenses (IOL) for treating cataracts. According to Abbott, the Tecnis Symfony lenses are currently the only ...

The Tecnis Symfony IOL is also available in four toric models, which are indicated for the reduction of residual refractive astigmatism or imperfections in the curvature of the eye. The Tecnis Symfony ...

The FDA has approved the Tecnis Symfony IOL for the treatment of cataracts, Abbott announced in a press release. The approval includes the Tecnis Symfony Toric IOL for people with astigmatism.

REDDING, CA--(Marketwired - Nov 10, 2016) - As a board-certified ophthalmologist with years of experience in laser vision correction and cataract surgery, Redding eye surgeon Michael Sumsion, MD is ...

IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...